Hans L. Mulder

Assen, DR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

High persistence and low treatment rates of metabolic syndrome in patients with mood and anxiety disorders: A naturalistic follow-up study.

High persistence and low treatment rates of metabolic syndrome in patients with mood and anxiety disorders: A naturalistic follow-up study.

Journal: Journal of affective disorders

Published: October 08, 2023

Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study.

Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study.

Journal: BMC psychiatry

Published: August 17, 2023

Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study.

Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study.

Journal: International journal of clinical pharmacy

Published: December 22, 2021

Anxiety and mood disorders are independent risk factors for cardiovascular diseases

Anxiety and mood disorders are independent risk factors for cardiovascular diseases

Journal: Nederlands tijdschrift voor geneeskunde

Published: December 02, 2021

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Journal: European journal of human genetics : EJHG

Published: September 27, 2021

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.

Journal: European journal of human genetics : EJHG

Published: July 09, 2021

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Published: May 12, 2021

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Journal: European journal of human genetics : EJHG

Published: January 12, 2021

Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use.

Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use.

Journal: BMC psychiatry

Published: July 30, 2020

Discontinuation of SSRIs and SNRIs

Discontinuation of SSRIs and SNRIs

Journal: Nederlands tijdschrift voor geneeskunde

Published: March 19, 2020

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial).

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial).

Journal: Journal of clinical psychopharmacology

Published: November 06, 2019

Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.

Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.

Journal: Psychiatric genetics

Published: October 22, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026